Advertisement

Topics

Cambrex announces expansion of R&D capabilities at Milan site

08:15 EDT 18 Jun 2018 | EPM Magazine

Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex, has announced that it will expand research and development capabilities at its Milan site.

Original Article: Cambrex announces expansion of R&D capabilities at Milan site

NEXT ARTICLE

More From BioPortfolio on "Cambrex announces expansion of R&D capabilities at Milan site"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...